Quetiapine abuse – myth or reality?
Authors:
- Helge WaalHWHelge Waal
- Jørn Henrik VoldJVJørn Henrik Vold
- Svetlana Ondrasova SkurtveitSSSvetlana Ondrasova Skurtveit
- 25 August 2020
- journal article
- research article
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 140 (12)
Abstract
25.08.2020: Kronikk - Kvetiapin blir i økende grad brukt som beroligende og søvngivende middel, særlig innen behandling av ruslidelser.Keywords
This publication has 16 references indexed in Scilit:
- 20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)World Psychiatry, 2020
- Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation AntipsychoticsSubstance Abuse: Research and Treatment, 2019
- Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and DiscoveryPharmacological Reviews, 2018
- Is There a Potential of Misuse for Quetiapine?Journal of Clinical Psychopharmacology, 2018
- Atypical antipsychotics for insomnia: a systematic reviewSleep Medicine, 2016
- Utilisation of extended release quetiapine (Seroquel XL™): Results from an observational cohort study in EnglandEuropean Psychiatry, 2016
- Fatal poisoning in drug addicts in the Nordic countries in 2012Forensic Science International, 2015
- Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disordersInternational Clinical Psychopharmacology, 2011
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)The Lancet, 2009
- Metabolic Consequences of Using Low-Dose Quetiapine for Insomnia in Psychiatric PatientsCommunity Mental Health Journal, 2009